Clinical Trial Update: A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip [NA]

View source ↗

Summary

A completed clinical trial evaluating the safety and effectiveness of Synvisc-One (Hylan G-F 20) for primary osteoarthritis of the hip; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip

Drugs mentioned

• Synvisc-One (hylan G-F 20)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Osteoarthritis, Hip | NA | Status: COMPLETED | Results posted: 2016-07-11